I have looked at many Bio stocks and ADO is very unique.
Many have drugs in development in Phase 1,2,3 etc or may have something else promising but have extremely high cash burn and no money and therefore the need to continuely raise money and dilute shareholders potential future EPS.
ADO is as DS says a ticket clipper - which what encourages me - The fact that ADO can access muti billion dollar markets and clip a precentage of that companies sales.
Ebio/Affy is but one company yet its annual contributions for ADO are in the $m's
I have had the opportunity to research fulltime over the last few years and there is no other stock I would rather have my money invested in.
I still believe the patent granting process has been critical and we are only just seeing the completion of the major grantings in the major geographical markets.
I expect MAJOR activity to increase in the back half of this year
Wouldnt it be interesting for the shareprice if a GLOBAL MAJOR needed ADO :)
ADO Price at posting:
5.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)